药物输送中的三维生物打印:一个广泛的频谱审查
Dongju Kim1,2, Seunguk Bang2,3
1Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Korean journal of anesthesiology
|September 15, 2025
概括
三维 (3D) 生物打印为疼痛管理提供定制的药物输送. 这项技术承诺精确,局部缓解疼痛,减少副作用并改善患者的康复.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 疼痛医学 医学 疼痛医学
背景情况:
- 三维 (3D) 生物打印正在通过可定制,可控释放系统彻底改变药物输送.
- 它在麻醉学和疼痛医学中的应用对局部化术后疼痛管理具有前景.
研究的目的:
- 审查3D生物打印在疼痛管理中用于药物输送的当前应用和未来方向.
- 突出3D生物打印在提供局部麻醉剂,抗炎药物和神经调节剂方面的潜力.
主要方法:
- 关于3D生物打印在治疗疼痛的药物输送中的应用现有文献的审查.
- 在3D打印系统中分析患者特定的设计和时空释放策略.
主要成果:
- 3D生物打印可实现精确,局部和持续的药物释放,以提高止痛效果.
- 针对患者的设计可以减少全身药物暴露,并改善组织恢复.
- 潜在的整合局部麻醉剂,抗炎药物和神经调节剂.
结论:
- 3D生物打印对在外科手术期间进行个性化,程序特定的疼痛管理具有显著的前景.
- 挑战包括监管,制造,可扩展性和生物相容性问题.
- 跨学科的合作是推动这项技术在临床应用中的关键.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Biopharmaceutical Factors Influencing Drug Product Design: Overview
561
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
561
Drug Delivery Systems: Different Types
420
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
420
Modified-Release Drug Delivery Systems: Overview
243
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
243
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


